Search Results - Gibson, C. Michael
- Showing 1 - 20 results of 87
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Admission Hyperglycemia and Acute Myocardial Infarction: Outcomes and Potential Therapies for Diabetics and Nondiabetics by Chakrabarti, Anjan K., Singh, Priyamvada, Gopalakrishnan, Lakshmi, Kumar, Varun, Elizabeth Doherty, Meagan, Abueg, Cassandra, Wang, Weici, Gibson, C. Michael
Published 2012Text -
6
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID‐19: Network meta‐analysis of randomized controlled trials by Chi, Gerald, Memar Montazerin, Sahar, Lee, Jane J., Kazmi, Syed Hassan A., Shojaei, Fahimehalsadat, Fitzgerald, Clara, Gibson, C. Michael
Published 2021Text -
7
-
8
Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS... by Gibson, William J., Gibson, C. Michael, Yee, Megan K., Korjian, Serge, Daaboul, Yazan, Plotnikov, Alexei N., Burton, Paul, Braunwald, Eugene
Published 2019Text -
9
Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead by Fabris, Enrico, Korjian, Serge, Coller, Barry S., Ten Berg, Jurrien M., Granger, Christopher B., Gibson, C. Michael, van ’t Hof, Arnoud W. J.
Published 2021Text -
10
Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death by Chan, Raymond H, Maron, Martin, Hong, Susie, Haas, Tammy S, Lesser, John, Gibson, C Michael, Manning, Warren J, Maron, Barry J, Appelbaum, Evan
Published 2012Text -
11
Antithrombotic Agents for Secondary Prevention after Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis by Fanaroff, Alexander C, Hasselblad, Victor, Roe, Matthew T, Bhatt, Deepak L, James, Stefan K, Steg, Ph Gabriel, Gibson, C Michael, Ohman, E Magnus
Published 2017Text -
12
Comparing baseline data from registries with trials: Evidence from the CathPCI Registry and DAPT Study by Butala, Neel M., Faridi, Kamil F., Secemsky, Eric, Song, Yang, Curtis, Jeptha, Gibson, C. Michael, Brindis, Ralph, Shen, Changyu, Yeh, Robert W.
Published 2021Text -
13
The AngelMed Guardian(®) System in the Detection of Coronary Artery Occlusion: Current Perspectives by Kazmi, Syed Hassan Abbas, Datta, Sudarshana, Chi, Gerald, Nafee, Tarek, Yee, Megan, Kalia, Akshun, Sharfaei, Sadaf, Shojaei, Fahimehalsadat, Mirwais, Sabawoon, Gibson, C Michael
Published 2020Text -
14
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() by Sofi, Francesco, Dinu, Monica, Reboldi, GianPaolo, Stracci, Fabrizio, Pedretti, Roberto F.E., Valente, Serafina, Gensini, GianFranco, Gibson, C. Michael, Ambrosio, Giuseppe
Published 2022Text -
15
Clinical Features, Use of Evidence‐Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non–ST‐Elevation Acute Coronary Syndrome by Rhee, June‐Wha, Wiviott, Stephen D., Scirica, Benjamin M., Gibson, C. Michael, Murphy, Sabina A., Bonaca, Marc P., Morrow, David A., Mega, Jessica L.
Published 2014Text -
16
Flurpiridaz F 18 PET: Phase II Safety and Clinical Comparison with SPECT Myocardial Perfusion Imaging for Detection of Coronary Artery Disease by Berman, Daniel S., Maddahi, Jamshid, Tamarappoo, B. K., Czernin, Johannes, Taillefer, Raymond, Udelson, James E., Gibson, C. Michael, Devine, Marybeth, Lazewatsky, Joel, Bhat, Gajanan, Washburn, Dana
Published 2012Text -
17
Clinical Implications and Correlates of Q Waves in Patients With ST‐Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY‐TIMI 28 Trial by Waks, Jonathan W., Sabatine, Marc S., Cannon, Christopher P., Morrow, David A., Gibson, C. Michael, Wiviott, Stephen D., Giugliano, Robert P., Sloan, Sarah, Scirica, Benjamin M.
Published 2014Text -
18
Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interve... by Capodanno, Davide, Di Maio, Marco, Greco, Antonio, Bhatt, Deepak L., Gibson, C. Michael, Goette, Andreas, Lopes, Renato D., Mehran, Roxana, Vranckx, Pascal, Angiolillo, Dominick J.
Published 2020Text -
19
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial by Dizon, José M, Brener, Sorin J, Maehara, Akiko, Witzenbichler, Bernard, Biviano, Angelo, Godlewski, Jacek, Parise, Helen, Dambrink, Jan-Henk, Mehran, Roxana, Gibson, C Michael, Stone, Gregg W
Published 2014Text -
20
Early Dynamic Risk Stratification with Baseline Troponin Levels and 90-minute ST Segment Resolution to Predict 30 Day Cardiovascular Mortality in STEMI: Analysis from CLARITY TIMI-... by Sherwood, Matthew W., Morrow, David A., Scirica, Benjamin M., Jiang, Songtao, Bode, Christoph, Rifai, Nader, Gerszten, Robert E., Gibson, C. Michael, Cannon, Christopher P., Braunwald, Eugene, Sabatine, Marc S.
Published 2010Text